Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: A double-blind, randomized pilot study
- 1 April 2000
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 22 (4), 411-419
- https://doi.org/10.1016/s0149-2918(00)89010-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- St. John's Wort for DepressionPublished by Ovid Technologies (Wolters Kluwer Health) ,1999
- Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytesBrain Research, 1999
- Maintenance Phase Efficacy of Sertraline for Chronic DepressionA Randomized Controlled TrialJAMA, 1998
- Adverse effects profile of the herbal antidepressant St. John's wort ( Hypericum perforatum L.)European Journal of Clinical Pharmacology, 1998
- Efficacy and Tolerability of St. John's Wort Extract LI 160 Versus Imipramine in Patients with Severe Depressive Episodes According to ICD-10Pharmacopsychiatry, 1997
- LI 160, an Extract of St. John's Wort, Versus Amitriptyline in Mildly to Moderately Depressed Outpatients - A Controlled 6-Week Clinical TrialPharmacopsychiatry, 1997
- St John's wort for depression--an overview and meta-analysis of randomised clinical trialsBMJ, 1996
- Comparative Study of Cerebral Ventricular Dilation and Cognitive Function in Patients with Alzheimer's Disease of Early versus Late OnsetJournal of Geriatric Psychiatry and Neurology, 1994
- A New Italian Pedigree with Early-Onset Alzheimer's DiseaseJournal of Geriatric Psychiatry and Neurology, 1994
- Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depressionInternational Clinical Psychopharmacology, 1993